Where it comes from
- Made in
- G cells of the gastric antrum and duodenum
- Sent out by
- Protein in the stomach, stretch of the stomach wall and vagal signals; acid in the antrum shuts it off
- Acts on
- Enterochromaffin-like cells (histamine release)
- Parietal cells
- Gastric lining (growth)
What it does
In medicine
- Measured for gastrinoma (Zollinger-Ellison syndrome), where it runs very high
- Pentagastrin, a synthetic fragment, was the acid-secretion test and a provocation test for medullary thyroid cancer; it is no longer made
- Netazepide, a gastrin receptor blocker, has shrunk gastric neuroendocrine tumours in small trials 2
Beyond the body’s own use
- Long-term proton-pump inhibitors raise gastrin several-fold. What that does to the stomach lining is still studied, and the moderate rises seen in practice have not been shown to cause cancer in people 1
- Netazepide cleared every tumour in five of the patients in a year-long open trial in autoimmune atrophic gastritis, and the tumours grew back when it was stopped 2; it is not approved
- A gastrin vaccine, G17DT, was taken into a randomised trial in 154 people with advanced pancreatic cancer and did not improve survival; it was never approved 3
Sources
- Rehfeld, Gastrin and the moderate hypergastrinaemias, International Journal of Molecular Sciences 2021
- Boyce et al., Netazepide can eradicate gastric neuroendocrine tumours, British Journal of Clinical Pharmacology 2017
- Gilliam et al., A randomised controlled trial of G17DT in pancreatic cancer, Pancreas 2012
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.